Fig. 5From: Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinomaComprehensive analysis of the differences in immune response genes between high-risk and low-risk patients in the training cohort. A and B Comparison of the CYT score (A), GZMA expression and PRF1 expression (B) between high-risk and low-risk patients in the training cohort. C Comparison of immune checkpoint expression (CD274, HAVCR2 and IDO1) between high-risk and low-risk patients in the training cohort. D Comparison of costimulatory and MHC molecule expression between high-risk and low-risk patients. E Comparison of chemokine expression between high-risk and low-risk patientsBack to article page